Tenet Healthcare Corporation (NYSE:THC – Get Free Report) EVP Thomas Arnst sold 24,000 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the transaction, the executive vice president directly owned 8,012 shares in the company, valued at approximately $1,875,128.48. This represents a 74.97% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Tenet Healthcare Stock Performance
NYSE THC opened at $244.10 on Thursday. The business’s 50-day moving average price is $208.54 and its 200 day moving average price is $201.39. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a twelve month low of $109.82 and a twelve month high of $245.98. The company has a market capitalization of $21.23 billion, a PE ratio of 15.76, a price-to-earnings-growth ratio of 1.20 and a beta of 1.39.
Tenet Healthcare (NYSE:THC – Get Free Report) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. During the same quarter in the prior year, the company posted $3.44 EPS. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, research analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.
Institutional Trading of Tenet Healthcare
Wall Street Analysts Forecast Growth
THC has been the topic of a number of research analyst reports. Morgan Stanley reiterated an “overweight” rating and issued a $260.00 target price on shares of Tenet Healthcare in a report on Thursday, February 12th. Guggenheim raised their price objective on Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a report on Friday, February 13th. Wells Fargo & Company reiterated an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a report on Monday, February 16th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday. Finally, Leerink Partners lifted their price target on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research report on Friday, February 20th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $247.67.
Check Out Our Latest Research Report on Tenet Healthcare
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Featured Stories
- Five stocks we like better than Tenet Healthcare
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
